{"id":9965,"date":"2025-06-26T14:54:56","date_gmt":"2025-06-26T06:54:56","guid":{"rendered":"https:\/\/www.excelsiormedical.com.tw\/?p=9965"},"modified":"2025-08-26T15:26:57","modified_gmt":"2025-08-26T07:26:57","slug":"the-2025-annual-shareholders-meeting-approved-the-companys-list-of-newly-elected-directors-including-independent-directors","status":"publish","type":"post","link":"https:\/\/www.excelsiormedical.com.tw\/en\/investors\/the-2025-annual-shareholders-meeting-approved-the-companys-list-of-newly-elected-directors-including-independent-directors\/","title":{"rendered":"The 2025 Annual Shareholders’ Meeting approved the Company’s list of newly elected directors (including independent directors)."},"content":{"rendered":"

 <\/p>\n\n\n\n\n\n\n
SEQ_NO<\/td>\n\u00a02<\/td>\nDate of announcement<\/td>\n2025\/06\/26<\/td>\nTime of announcement<\/td>\n14:54:56<\/td>\n<\/tr>\n
Subject<\/td>\n\n
The 2025 Annual Shareholders' Meeting approved\r\nthe Company's list of newly elected directors\r\n(including independent directors).<\/pre>\n<\/td>\n<\/tr>\n
Date of events<\/td>\n2025\/06\/26<\/td>\nTo which item it meets<\/td>\nparagraph 6<\/td>\n<\/tr>\n
Statement<\/td>\n\n
1.Date of occurrence of the change:2025\/06\/26\r\n2.Elected or changed position (Please enter institutional director,\r\ninstitutional supervisor, independent director, natural-person director or\r\nnatural-person supervisor):\r\nInstitutional director,independent director,natural-person director.\r\n3.Title and name of the previous position holder:\r\nInstitutional director:\r\nExcelsior Group Holdings Co., Ltd. Representative:Chen Tun-Ling\r\nExcelsior Group Holdings Co., Ltd. Representative:Chang Hsien-Cheng\r\nNatural-person director:\r\nFu Hui-Tung\r\nChang Ming-Cheng\r\nHsieh Yen-Sheng\r\nFu Jo-Hsuan\r\nIndependent director:\r\nChang Wu-I\r\nKuo Yu-Chia\r\nChan,Chien-Lung\r\n4.Resume of the previous position holder:\r\nInstitutional director:\r\nExcelsior Group Holdings Co., Ltd. Representative:\r\nChen Tun-Ling\u2014Director of the Company.\r\nExcelsior Group Holdings Co., Ltd. Representative:\r\nChang Hsien-Cheng\u2014Director of the Company.\r\nNatural-person director:\r\nFu Hui-Tung\u2014Director of the Company.\r\nChang Ming-Cheng\u2014CEO of the Company.\r\nHsieh Yen-Sheng\u2014Director of the Company.\r\nFu Jo-Hsuan\u2014Director of the Company.\r\nIndependent director:\r\nChang Wu-I\u2014Director of the Company.\r\nKuo Yu-Chia\u2014Director of the Company.\r\nChan,Chien-Lung\u2014Director of the Company.\r\n5.Title and name of the new position holder:\r\nInstitutional director:\r\nExcelsior Group Holdings Co., Ltd. Representative:Chen Tun-Ling\r\nExcelsior Group Holdings Co., Ltd. Representative:Chang Hsien-Cheng\r\nNatural-person director:\r\nFu Hui-Tung\r\nChang Ming-Cheng\r\nHsieh Yen-Sheng\r\nFu Jo-Hsuan\r\nIndependent director:\r\nChan,Chien-Lung\r\nKuo,Ming-Yi\r\nHuang,Chung-Chen\r\n6.Resume of the new position holder:\r\nInstitutional director:\r\nExcelsior Group Holdings Co., Ltd. Representative:\r\nChen Tun-Ling\u2014Director of the Company.\r\nExcelsior Group Holdings Co., Ltd. Representative:\r\nChang Hsien-Cheng\u2014Director of the Company.\r\nNatural-person director:\r\nFu Hui-Tung\u2014Director of the Company.\r\nChang Ming-Cheng\u2014Director of the Company.\r\nHsieh Yen-Sheng\u2014Director of the Company.\r\nFu Jo-Hsuan\u2014Director of the Company.\r\nIndependent director:\r\nChan,Chien-Lung\u2014Principal of Soochow University.\r\nKuo,Ming-Yi\u2014Consultant of Lexcel Legal Office.\r\nHuang,Chung-Chen\u2014Director of Jinli Refractory Company.\r\n7.Circumstances of change (Please enter \u201cresignation\u201d, \u201cdismissal\u201d,\r\n\u201cterm expired\u201d, \u201cdeath\u201d or \u201cnew appointment\u201d):term expired\r\n8.Reason for the change:Term expired and full re-election.\r\n9.Number of shares held by the new position holder when elected:\r\nInstitutional director:\r\nExcelsior Group Holdings Co., Ltd.(17,287,235 shares)\r\nRepresentative:Chen Tun-Ling(632,641 shares)\r\nExcelsior Group Holdings Co., Ltd.(17,287,235 shares)\r\nRepresentative:Chang Hsien-Cheng(17,363 shares)\r\nNatural-person director:\r\nFu Hui-Tung(544,074 shares)\r\nChang Ming-Cheng (179,472 shares)\r\nHsieh Yen-Sheng(742,269 shares)\r\nFu Jo-Hsuan(115,762 shares)\r\nIndependent director:\r\nChan,Chien-Lung(0 shares)\r\nKuo,Ming-Yi(0 shares)\r\nHuang,Chung-Chen(0 shares)\r\n10.Original term (from __________ to __________):2022\/06\/21~2025\/06\/20\r\n11.Effective date of the new appointment:2025\/06\/26\r\n12.Turnover rate of directors of the same term:Not Applicable.\r\n13.Turnover rate of independent directors of the same term:Not Applicable.\r\n14.Turnover rate of supervisors of the same term:Not Applicable.\r\n15.Change in one-third or more of directors (Please enter \u201cYes\u201d or\r\n\u201cNo\u201d):No.\r\n16.Any other matters that need to be specified (the information disclosure\r\nalso meets the requirements of Article 7, subparagraph 6 of the Securities\r\nand Exchange Act Enforcement Rules, which brings forth a significant impact\r\non shareholders rights or the price of the securities on public companies.):\r\nNone.<\/pre>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"
  SEQ_NO \u00a02 Date of announcement 2025\/06\/26 Time of announcement 14:54:56 Subject The 2025 Annual Shareholders’ Meeting approved the Company’s list of newly elected directors (including independent directors). Date of events 2025\/06\/26 To which item it meets paragraph 6 Statement 1.Date of occurrence of the change:2025\/06\/26 2.Elected or changed position (Please enter institutional director, institutional …<\/p>\n
  The 2025 Annual Shareholders’ Meeting approved the Company’s list of newly elected directors (including independent directors).<\/span> Read More »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[72,102],"tags":[],"class_list":["post-9965","post","type-post","status-publish","format-standard","hentry","category-investors","category-material-information"],"_links":{"self":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9965","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/comments?post=9965"}],"version-history":[{"count":1,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9965\/revisions"}],"predecessor-version":[{"id":9966,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9965\/revisions\/9966"}],"wp:attachment":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/media?parent=9965"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/categories?post=9965"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/tags?post=9965"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}